Vault-13

Paradigm Biocapital Advisors LP

NEW YORK, NY · CIK 1855655 · 13F filing filed 2026-02-17

SEC-registered investment adviser since 2021 · limited partnership

As an employer

$3.7bn reported value +10.5% vs Q3 2025
29positions
73.8%in top 10
8 new 11 added 7 reduced 12 sold out vs Q3 2025

Options: 0 call positions (— notional), 1 put positions ($182.9m notional) – listed below, not included above.

Holdings, Q4 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NUVALENT INC COM COM 5,269,433 $530.1m14.19% 14.19% UnchangedShares held: Q1 2025 5.3m, Q2 2025 5.3m, Q3 2025 5.3m, Q4 2025 5.3m
2 REVOLUTION MEDICINES INC COM RVMD RVMD 6,644,403 $529.2m14.17% 14.17% AddedShares held: Q1 2025 6.2m, Q2 2025 6.1m, Q3 2025 6.2m, Q4 2025 6.6m +421.1k +421,112 6.8%
3 ARCELLX INC COMMON STOCK ACLX ACLX 5,724,016 $373.2m9.99% 9.99% AddedShares held: Q1 2025 4.5m, Q2 2025 4.6m, Q3 2025 4.6m, Q4 2025 5.7m +1.1m +1,075,000 23.1%
4 GENMAB A/S SPONSORED ADS GMAB GMAB 7,039,834 $216.8m5.81% 5.81% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 3.8m, Q4 2025 7.0m +3.2m +3,222,983 84.4%
5 TARSUS PHARMACEUTICALS INC COM TARS TARS 2,562,154 $209.8m5.62% 5.62% ReducedShares held: Q1 2025 2.6m, Q2 2025 3.0m, Q3 2025 2.7m, Q4 2025 2.6m -103.5k -103,544 -3.9%
6 ABIVAX SA SPONSORED ADS ABVX ABVX 1,417,473 $191.2m5.12% 5.12% ReducedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 1.6m, Q4 2025 1.4m -146.7k -146,723 -9.4%
7 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 7,544,172 $188.6m5.05% 5.05% AddedShares held: Q1 2025 6.7m, Q2 2025 6.8m, Q3 2025 6.8m, Q4 2025 7.5m +750.0k +750,000 11.0%
8 VAXCYTE INC COM PCVX PCVX 4,068,020 $187.7m5.03% 5.03% AddedShares held: Q1 2025 1.7m, Q2 2025 3.4m, Q3 2025 3.8m, Q4 2025 4.1m +283.3k +283,265 7.5%
9 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 759,565 $167.8m4.49% 4.49% ReducedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 961.2k, Q4 2025 759.6k -201.6k -201,599 -21.0%
10 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 6,541,210 $162.3m4.35% 4.35% AddedShares held: Q1 2025 4.4m, Q2 2025 6.1m, Q3 2025 6.2m, Q4 2025 6.5m +371.1k +371,079 6.0%
11 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 3,062,157 $134.9m3.61% 3.61% AddedShares held: Q1 2025 0, Q2 2025 1.6m, Q3 2025 2.0m, Q4 2025 3.1m +1.1m +1,052,412 52.4%
12 UROGEN PHARMA LTD COM URGN URGN 4,473,648 $104.8m2.81% 2.81% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 4.2m, Q4 2025 4.5m +257.6k +257,564 6.1%
13 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 2,210,774 $102.9m2.76% 2.76% ReducedShares held: Q1 2025 1.9m, Q2 2025 2.3m, Q3 2025 2.6m, Q4 2025 2.2m -340.0k -340,000 -13.3%
14 APOGEE THERAPEUTICS INC COM COM 1,123,243 $84.8m2.27% 2.27% ReducedShares held: Q1 2025 961.7k, Q2 2025 958.6k, Q3 2025 1.5m, Q4 2025 1.1m -398.5k -398,514 -26.2%
15 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 3,691,475 $67.4m1.81% 1.81% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 2.0m, Q4 2025 3.7m +1.7m +1,686,110 84.1%
16 ERASCA INC COM ERAS ERAS 14,159,095 $52.7m1.41% 1.41% AddedShares held: Q1 2025 10.8m, Q2 2025 11.9m, Q3 2025 13.6m, Q4 2025 14.2m +599.1k +599,078 4.4%
17 BRIDGEBIO PHARMA INC COM BBIO BBIO 684,277 $52.3m1.40% 1.40% UnchangedShares held: Q1 2025 0, Q2 2025 965.8k, Q3 2025 684.3k, Q4 2025 684.3k
18 ORUKA THERAPEUTICS INC COM ORKA ORKA 1,710,316 $51.8m1.39% 1.39% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 1.7m
19 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 1,467,266 $48.1m1.29% 1.29% UnchangedShares held: Q1 2025 2.1m, Q2 2025 1.9m, Q3 2025 1.5m, Q4 2025 1.5m
20 LEXEO THERAPEUTICS INC COM LXEO LXEO 4,763,198 $47.3m1.27% 1.27% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 4.8m
21 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,443,102 $44.9m1.20% 1.20% ReducedShares held: Q1 2025 2.1m, Q2 2025 2.7m, Q3 2025 2.6m, Q4 2025 1.4m -1.2m -1,166,251 -44.7%
22 OCULAR THERAPEUTIX INC COM OCUL OCUL 2,935,284 $35.6m0.95% 0.95% ReducedShares held: Q1 2025 1.3m, Q2 2025 3.4m, Q3 2025 3.5m, Q4 2025 2.9m -562.0k -562,023 -16.1%
23 TERNS PHARMACEUTICALS INC COM COM 810,286 $32.7m0.88% 0.88% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 810.3k
24 BRIDGEBIO ONCOLOGY THERAPEUT COM NEW BBOT BBOT 2,261,749 $28.3m0.76% 0.76% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 1.9m, Q4 2025 2.3m +395.6k +395,608 21.2%
25 VOR BIOPHARMA INC COM NEW VOR VOR 1,750,000 $22.9m0.61% 0.61% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 1.8m
26 ASSEMBLY BIOSCIENCES INC COM NEW ASMB ASMB 665,251 $22.6m0.61% 0.61% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 665.3k
27 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,401,217 $19.6m0.53% 0.53% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 2.4m
28 INVENTIVA SA ADS IVA IVA 4,000,000 $18.6m0.50% 0.50% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 4.0m
29 KALARIS THERAPEUTICS INC COM KLRS KLRS 700,000 $5.9m0.16% 0.16% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 700.0k

Sold out since Q3 2025

SecurityTickerShares held beforeValue then
MERUS N V MRUS MRUS 4,373,770 $411.8m4.4m shares
AGIOS PHARMACEUTICALS INC AGIO AGIO 2,673,555 $107.3m2.7m shares
JANUX THERAPEUTICS INC JANX JANX 2,920,258 $71.4m2.9m shares
ALKERMES PLC ALKS ALKS 1,719,334 $51.6m1.7m shares
LENZ THERAPEUTICS INC LENZ LENZ 1,073,461 $50.0m1.1m shares
PHARVARIS N V PHVS PHVS 1,835,494 $45.8m1.8m shares
COGENT BIOSCIENCES INC COGT COGT 3,156,398 $45.3m3.2m shares
TANGO THERAPEUTICS INC TNGX TNGX 3,086,184 $25.9m3.1m shares
AMYLYX PHARMACEUTICALS INC AMLX AMLX 1,900,000 $25.8m1.9m shares
DYNE THERAPEUTICS INC DYN DYN 1,898,950 $24.0m1.9m shares
DISC MEDICINE INC IRON IRON 247,716 $16.4m247.7k shares
STRUCTURE THERAPEUTICS INC GPCR GPCR 372,869 $10.4m372.9k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 1,500,000 $182.9m1.5m shares Added

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
OLEMA PHARMACEUTICALS INC OLMA · 13G · filed 2025-02-14 OLMA 10.0%≈ $92.9m 13G 2025-02-14
EDGEWISE THERAPEUTICS INC EWTX · 13G · filed 2026-08-14 EWTX 9.5%≈ $415.1m +3.3 pts 13G 2026-08-14
ACHIEVE LIFE SCIENCES INC ACHV · 13G · filed 2026-04-24 ACHV 9.2%≈ $64.7m new 13G 2026-04-24
ASSEMBLY BIOSCIENCES INC ASMB · 13G · filed 2026-08-14 ASMB 7.8%≈ $42.7m +2.4 pts 13G 2026-08-14
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-08-14 VRDN 6.1%≈ $123.5m +1.0 pts 13G 2026-08-14
TYRA BIOSCIENCES INC TYRA · 13G · filed 2026-09-17 TYRA 5.8%≈ $110.9m new 13G 2026-09-17
LEXEO THERAPEUTICS INC LXEO · 13G · filed 2026-08-14 LXEO 5.3%≈ $19.4m -3.0 pts 13G 2026-08-14
MBX BIOSCIENCES INC MBX · 13G · filed 2026-06-24 MBX 5.2%≈ $137.6m new 13G 2026-06-24
SPYRE THERAPEUTICS INC SYRE · 13G · filed 2026-10-01 SYRE 5.1%≈ $395.7m new 13G 2026-10-01
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-07-17 JBIO 5.1%≈ $69.0m new 13G 2026-07-17